BBOX1 and neoplasm: In ESCC, BBOX1-AS1 activates the Wnt/β-catenin pathway by upregulating HOXB7 expression, enhancing the malignant behavior of ESCC cells, including cell proliferation, migration, and invasion, thereby promoting tumor progression [43].